NHS North of England Branded Medicines Tranche A & Annual Tranche
key details
| Value | £653,653,647 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 24 Oct 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-036b0f |
Awards (29)
This procurement was awarded to 29 suppliers. Values shown are per-award; the notice total is £653,653,647.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | · | · | active |
| Accord-UK Ltd shared | · | · | active |
| Almirall shared | · | · | active |
| Amgen Ltd shared | · | · | active |
| AstraZeneca shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Celltrion Healthcare United Kingdom Limited shared | · | · | active |
| Chugai Pharma UK Ltd shared | · | · | active |
| Eli Lilly and Company Ltd shared | · | · | active |
| Gedeon Richter UK Ltd shared | · | · | active |
| GlaxoSmithKline UK Limited shared | · | · | active |
| Ipsen shared | · | · | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Merck Serono Limited shared | · | · | active |
| Merck Sharpe and Dohme (UK) Limited shared | · | · | active |
| Merz shared | · | · | active |
| Novo Nordisk shared | · | · | active |
| Organon Pharmaceuticals UK Ltd shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Pharmacosmos UK Ltd shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | · | · | active |
| Takeda UK Ltd shared | · | · | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | · | · | active |
| UCB Pharma Ltd (primary) shared | · | · | active |
| Vifor Pharma UK Ltd shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.<br/>Offer reference number: CM/PHR/20/5606<br/>CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months<br/>CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 Sept 2022 | Contract notice (F02) | Earlier regulations | 026723-2022 |
| 15 Mar 2023 | Contract award notice (F03) | Earlier regulations | 007498-2023 |
more from NHS England
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.